Journal article 195 views 25 downloads
Effects of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across body mass index categories in type 2 diabetes: results of the LEADER and SUSTAIN 6 trials
Subodh Verma,
Darren K. McGuire,
Steve Bain 
,
Deepak L. Bhatt,
Lawrence A. Leiter,
C. David Mazer,
Tea Monk Fries,
Richard E. Pratley,
Søren Rasmussen,
Hrvoje Vrazic,
Bernard Zinman,
John B. Buse
,
Deepak L. Bhatt,
Lawrence A. Leiter,
C. David Mazer,
Tea Monk Fries,
Richard E. Pratley,
Søren Rasmussen,
Hrvoje Vrazic,
Bernard Zinman,
John B. Buse
Diabetes, Obesity and Metabolism, Volume: 22, Issue: 12
Swansea University Author:
Steve Bain
-
PDF | Accepted Manuscript
Download (648.14KB)
DOI (Published version): 10.1111/dom.14160
Abstract
Effects of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across body mass index categories in type 2 diabetes: results of the LEADER and SUSTAIN 6 trials
| Published in: | Diabetes, Obesity and Metabolism |
|---|---|
| ISSN: | 1462-8902 1463-1326 |
| Published: |
Wiley
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa54840 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Issue: |
12 |
|---|